ChemoTech is a Scandinavian Company based at Medicon Village in Lund, Sweden. The Company’s founders have extensive experience of cancer treatment through surgical oncology and clinical development. The Company is dedicated to using its unique patented know-how to develop innovation in cancer care through genuine research and clinical trials.
Following extensive research and development, ChemoTech launched the IQwave™ – TSE™ (Tumour Specific Electroporation) with gentle yet effective and flexible treatment capabilities for a wide range of tumours. IQwave™ has been developed to achieve positive clinical outcomes on a level previously not possible. Read more»
The next step for ChemoTech is to amongst other expand its product portfolio into effective pain management for cancer patients.
ChemoTech has established distribution channels and a network of key opinion leaders within the human medicine business area mainly in the markets of the Middle East, Asia, India and Africa and currently has distributor agreements in the Philippines, India, Malaysia, Vietnam, Myanmar, Kenya, Nigeria and Ukraine.